In ₹ Crore except Per Share 12 Months Ending | Q3 FY24 31/12/2023 | Q4 FY24 31/03/2024 | Q1 FY25 30/06/2024 | Q2 FY25 30/09/2024 | Q3 FY25 31/12/2024 | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 123.2 | 116.7 | 88.7 | 109.3 | 145.3 | 118.8 | 87.0 | 90.5 | 174.6 | 137.5 | 107.3 | |
| Other Income | 0.1 | 0.3 | 0.4 | 0.2 | 0.2 | 0.0 | 0.0 | 0.0 | 0.5 | 5.8 | 0.0 | |
| Total Income | 123.3 | 117.0 | 89.1 | 109.5 | 145.5 | 118.8 | 87.0 | 90.5 | 175.1 | 143.2 | 107.3 | |
| Expenses | ||||||||||||
| + Cost of Materials Consumed | 14.7 | 7.7 | 6.2 | 29.5 | 23.3 | 2.6 | 7.6 | 0.4 | 27.9 | 9.9 | 14.9 | |
| + Purchases of Stock-in-Trade | 128.9 | 106.1 | 65.1 | 82.0 | 111.0 | 83.1 | 60.3 | 70.0 | 140.9 | 114.0 | 166.5 | |
| + Changes in Inventories | -45.8 | -19.3 | 2.6 | -25.2 | -17.6 | 9.8 | 2.3 | -15.5 | -37.4 | -0.1 | -95.7 | |
| + Employee Benefit Expense | 2.9 | 2.4 | 2.2 | 2.5 | 3.3 | 2.8 | 2.4 | 2.5 | 3.8 | 2.9 | 2.7 | |
| + Finance Costs | 5.1 | 2.4 | 2.1 | 1.9 | 1.9 | 1.8 | 1.5 | 1.3 | 1.2 | 2.0 | 1.1 | |
| + Depreciation & Amortisation | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 0.5 | 0.4 | 0.4 | |
| + Other Expenses | 2.5 | 2.2 | 1.9 | 3.2 | 2.4 | 3.1 | 1.7 | 2.5 | 4.1 | 2.3 | 2.5 | |
| Total Expenses | 108.7 | 101.9 | 80.6 | 94.3 | 124.9 | 103.7 | 76.3 | 61.7 | 141.0 | 131.5 | 92.5 | |
| EBITDA | 20.0 | 17.7 | 10.7 | 17.4 | 22.9 | 17.4 | 12.8 | 30.5 | 35.3 | 8.4 | 16.3 | |
| EBIT | 19.6 | 17.1 | 10.2 | 16.9 | 22.4 | 16.9 | 12.3 | 30.1 | 34.8 | 7.9 | 15.9 | |
| Profit | ||||||||||||
| PBT before Exceptional Items | 14.6 | 15.1 | 8.5 | 15.2 | 20.6 | 15.1 | 10.8 | 28.8 | 34.1 | 11.7 | 14.8 | |
| + Exceptional Items | 0.0 | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.3 | 0.0 | |
| Pretax Income | 14.6 | 15.7 | 8.5 | 15.2 | 20.6 | 15.1 | 10.8 | 28.8 | 34.1 | 11.4 | 14.8 | |
| + Current Tax | 3.8 | 4.9 | 2.1 | 4.8 | 5.2 | 4.0 | 2.7 | 7.3 | 8.8 | 3.2 | 3.8 | |
| + Deferred Tax | -0.0 | 0.0 | 0.0 | -0.0 | 0.1 | -0.1 | 0.0 | 0.1 | -0.7 | -0.1 | 0.0 | |
| Tax Expense | 3.8 | 4.9 | 2.2 | 4.8 | 5.3 | 3.9 | 2.8 | 7.4 | 8.1 | 3.1 | 3.8 | |
| Net Income | 10.8 | 10.8 | 6.3 | 10.4 | 15.3 | 11.1 | 8.0 | 21.4 | 25.9 | 8.3 | 11.0 | |
| + Net Income — Continuing Ops | 10.8 | 10.8 | 6.3 | 10.4 | 15.3 | 11.1 | 8.0 | 21.4 | 25.9 | 8.3 | 11.0 | |
| + Other Comprehensive Income | -0.0 | -0.0 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | -0.0 | 0.0 | 0.0 | -0.1 | |
| Total Comprehensive Income | 10.8 | 10.8 | 6.3 | 10.4 | 15.3 | 11.1 | 8.0 | 21.4 | 26.0 | 8.3 | 10.9 | |
| Per Share | ||||||||||||
| Basic EPS | 1.51 | 1.10 | 0.64 | 1.06 | 0.25 | 0.11 | 0.08 | 0.22 | 0.26 | 0.08 | 0.11 | |
| Diluted EPS | 1.51 | 1.10 | 0.64 | 1.06 | 0.23 | 0.10 | 0.07 | 0.20 | 0.24 | 0.08 | 0.11 | |
| Other Comprehensive Income — detail | ||||||||||||
| + Other Comprehensive Income | — | — | — | — | — | 0.0 | 0.0 | -0.0 | 0.0 | 0.0 | -0.1 | |
| + Items NOT to be Reclassified to P&L | — | -0.0 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | -0.0 | 0.0 | 0.0 | -0.1 | |
| Per Share — as-filed variants | ||||||||||||
| Basic EPS — Continuing Operations | 1.51 | 1.10 | 0.64 | 1.06 | 0.25 | 0.11 | 0.08 | 0.22 | 0.26 | 0.08 | 0.11 | |
| Diluted EPS — Continuing Operations | 1.51 | 1.10 | 0.64 | 1.06 | 0.23 | 0.10 | 0.07 | 0.20 | 0.24 | 0.08 | 0.11 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | ||||||||||||
| Related-party Transactions — During the Period | — | — | — | — | — | 37.6 | — | 40.1 | — | 58.8 | — | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | ||||||||||||
| Gross Profit | 25.4 | 22.2 | 14.8 | 23.1 | 28.6 | 23.3 | 16.8 | 35.6 | 43.2 | 13.6 | 21.6 | |
| Gross Margin % | 20.60 | 19.05 | 16.67 | 21.15 | 19.69 | 19.60 | 19.34 | 39.36 | 24.72 | 9.92 | 20.12 | |
| Adjusted (ex-Exceptional Items) — derived | ||||||||||||
| Pretax Income (Adjusted, as filed) | 14.6 | 15.1 | 8.5 | 15.2 | 20.6 | 15.1 | 10.8 | 28.8 | 34.1 | 11.7 | 14.8 | |
| − Exceptional Items (reconciliation) | 0.0 | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.3 | 0.0 | |
| Net Income Adj (tax-effected) | 10.8 | 10.4 | 6.3 | 10.4 | 15.3 | 11.1 | 8.0 | 21.4 | 25.9 | 8.5 | 11.0 | |
| EPS Adj | 1.51 | 1.06 | 0.64 | 1.06 | 0.25 | 0.11 | 0.08 | 0.22 | 0.26 | 0.08 | 0.11 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | ||||||||||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Paid Up Equity Capital | 98.4 | 98.4 | 98.4 | 98.4 | 98.4 | 98.4 | 98.4 | 98.4 | 98.8 | 100.2 | 113.8 | |